The Federal Circuit on Friday vacated and remanded a final written decision from the Patent Trial and Appeal Board concluding ...

First in class study of an investigational ACTH receptor antagonist aims to address significant unmet need in children and ...

The Roper Technologies conference call will now begin. Zack Moxcey: Good morning, and thank you all for joining us as we ...

Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

The endothelial glycocalyx integrates mechanical signals with vascular biology, playing a vital role in health and disease, ...

Ongoing phase 3 trials target improved therapies for hematologic malignancies, focusing on CLL, multiple myeloma, and ...